Previous 10 | Next 10 |
– IBIO-201 Produced Anti-Spike Neutralizing Antibodies in Pre-Clinical Studies – – iBio Plans to Continue Development of IBIO-200, its Virus-Like Particle Platform – NEW YORK, Sept. 09, 2020 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSE AMERICAN:IBIO) (“i...
Intra-Cellular Therapies (ITCI +74% on positive topline results from its Phase 3 clinical trial. More news on: Astrotech Corporation, Vaxart, Inc., Chembio Diagnostics, Inc., Stocks on the move, , Read more ...
Many COVID-19 vaccine players are in the green premarket in apparent response to a potential safety signal in a Phase 3 study of AstraZeneca's (NYSE: AZN ) AZD1222. AZN is down 2% on light volume. More news on: AstraZeneca PLC, Sanofi, GlaxoSmithKline plc, Healthcare stocks...
Corbus Pharmaceuticals (NASDAQ: CRBP ) -75% after announcing topline results from RESOLVE-1 study of Lenabasum. More news on: Corbus Pharmaceuticals Holdings, Inc., PolyMet Mining Corp., Tesla, Inc., Stocks on the move, , Read more ...
Should These Penny Stocks be On Your Buy Or Sell List This Week? Is the stock market open on Labor Day ? The answer is no , but that doesn’t mean the millions of users on WeBull, TD Ameritrade, Robinhood, etc. can’t find top penny stocks to watch this week. If anything, the e...
One of my investments is in a small COVID vaccine company, Heat Biologics ( HTBX ), and I generally route for the little guy. So I don't particularly like writing an article that has a number of facts and reasons why probably none of the remaining small players are going to become major player...
AstraZeneca (NYSE: AZN ) has expanded development of its COVID-19 vaccine AZD1222 into Phase III clinical trial in the U.S. to assess its safety, efficacy and immunogenicity. More news on: AstraZeneca PLC, Moderna, Inc., Pfizer Inc., Healthcare stocks news, Read more ...
Shares of iBio (NYSEMKT: IBIO) climbed on Friday after the biologics manufacturer announced an exclusive global license agreement with Planet Biotechnology for the development of its experimental COVID-19 therapy. As of 1:25 p.m. EDT, iBio's stock was up 5% after rising as much as 18.5% earl...
Are These On Your List Of Penny Stocks To Buy Today? Penny stocks are one of those things that people either love or love to hate. When it comes to the latter, it likely stems from misinformation. Whether it’s misinformation on how to trade them or misinformation they used as due dili...
IBio (NYSEMKT: IBIO ) inks an agreement with Planet Biotechnology securing exclusive global rights to the latter's COVID-19 therapeutic candidate ACE2-Fc, a recombinant protein consisting of human angiotensin-converting enzyme 2 (ACE2) fused to a human immunoglobulin G Fc fragment. M...
News, Short Squeeze, Breakout and More Instantly...
– The sale of the facility eliminates $13.2M of secured debt – – Completes iBio’s transition to an AI and precision biologics innovation company - SAN DIEGO, June 03, 2024 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or th...
2024-05-28 07:30:05 ET Chardan Capital analyst issues BUY recommendation for IBIO on May 28, 2024 05:34AM ET. IBIO was trading at $2.19 at issue of the analyst recommendation. The overall analyst consensus : HOLD. Current analyst recommendations are : 1 - Hold recommenda...
Strengthened cash position with investment by healthcare specialist investors Expanding into cardio-metabolic space through AstralBio collaboration BRYAN, Texas and SAN DIEGO, May 13, 2024 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company...